GlassScriptPhysician profile
Matthew Campbell
NPI 1811019722
$22,955.77
in general payments reported to CMS, 2019-2025
25 companies · $3,033 in 2025
The $3,033 reported for 2025 was more than what 75% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,688 · 2020: $370 · 2021: $1,365 · 2022: $11K · 2023: $3,185 · 2024: $2,107 · 2025: $3,033.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,755 · Travel and Lodging: $2,571.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,755.13 |
| Travel and Lodging | $2,570.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,500.47 | 2021-2025 | Corevalve Evolut R, Avalus |
| Abbott Laboratories | $3,369.65 | 2020-2025 | Mitraclip, Navitor |
| Edwards Lifesciences Corporation | $3,270.72 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Mitris Resilia Mitral Valve |
| Intuitive Surgical, INC. | $1,317.27 | 2022-2023 | Da Vinci Surgical System |
| Abiomed | $1,239.43 | 2019-2025 | Impella |
| Cvrx, INC. | $794.25 | 2021-2025 | Barostim Neo System |
| Atricure, INC. | $771.01 | 2019-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Medtronic Vascular, INC. | $588.77 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $498.26 | 2021-2024 | Gore Tag Thoracic Branch Endoprosthesis, Gore Tag Thoracic Endoprosthesis |
| Getinge USA Sales, LLC | $422.58 | 2021-2025 | Vasoview Hemopro 2 |
| Artivion, INC. | $329.18 | 2019-2025 | Cardiac Non-Synergraft, Bioglue Surgical Adhesive, Photofix Decellularized Bovine Pericardium |
| Boston Scientific Corporation | $300.74 | 2019-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $116.29 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $79.91 | 2019-2021 | |
| Bard Access Systems, INC. | $70.82 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $60.17 | 2019-2023 | Progel Applicator Spray Tips |
| Kls-Martin L.P. | $50.72 | 2020-2022 | |
| Lsi Solutions INC | $49.10 | 2019 | |
| Baxter Healthcare | $31.96 | 2021-2022 | |
| Chiesi USA, INC. | $22.60 | 2021 | |
| Teleflex LLC | $21.60 | 2021 | |
| Pfizer INC. | $16.65 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.08 | 2021 | |
| Livanova USA, INC. | $11.04 | 2021 | |
| Penumbra, INC. | $7.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.